Heart Test Laboratories Inc (HSCS) Stock Price, Quote & News

Company Profile

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insig...

Industry: Medical Devices

Sector: Healthcare

Phone: 682 237 7781

Website: heartsciences.com

Address:

550 Reserve Street, Suite 360, Southlake, United States

Mikeqb20 Aug. 3 at 11:22 AM

$GIFT $RITR $RCEL $HSCS $CRE MAESTRO LOVES GIFT....

0 · Reply

johnnylawrencecobra Aug. 3 at 9:28 AM

$CRE $GIFT $HSCS $RCEL $RITR $GIFT on HIGH ALERT

0 · Reply

johnnylawrencecobra Aug. 3 at 9:27 AM

$CRE $GIFT $HSCS $RCEL $RITR LOVE $GIFT

0 · Reply

DrTampa Aug. 3 at 8:04 AM

$HSCS volume of 2600 shares at 4:03am is crazy for this stock lol nice spread on level 2

0 · Reply

Zeestallion Aug. 3 at 3:16 AM

$QTEX $ATKR $HSCS $MODD 💎 VIVS - 👈⏲️💣🚀 This is the next big thing the market still hasn’t caught onto. ──────────────── Get in early. Load the boat. 🚢🚢🚢 ──────────────── Tiny market cap. Real cash. Big pharma already involved. Actual data stacking. Most people will only notice once it’s much higher. 📈

0 · Reply

topstockalerts Aug. 3 at 12:23 AM

After Hours Top Gainers PT2 $RITR $GIFT $RCEL $HSCS $CRE

0 · Reply

topstockalerts Aug. 1 at 7:31 PM

After Hours Top Gainers PT2 $RITR $GIFT $RCEL $HSCS $CRE

0 · Reply

Zeestallion Aug. 1 at 5:57 PM

$VIVS $UPC $FCUV $HSCS Couldn't have agreed more twin ⏲️💣 There's a reason why a TRILLION dollar pharmaceutical company is funding this. They know this would change the industry's landscape 👂

0 · Reply

Mikeqb20 Aug. 1 at 2:53 PM

$RITR $RCEL $HSCS $CRE $GIFT

0 · Reply

topstockalerts Aug. 1 at 1:06 AM

After Hours Top Gainers PT2 $RITR $RCEL $HSCS $CRE $GIFT

0 · Reply

HeartSciences Proxy statement: Proxy filing

Jul 29, 2026, 9:00 AM EDT - 6 days ago

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Jul 29, 2026, 8:00 AM EDT - 6 days ago

HeartSciences Proxy statement: Proxy filing

Jul 29, 2026, 8:00 AM EDT - 6 days ago

HeartSciences Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 7 days ago

HeartSciences Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 7 days ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 8 days ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 8 days ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 8 days ago

HeartSciences Proxy statement: Proxy filing

Jul 23, 2026, 5:15 PM EDT - 11 days ago

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Jul 23, 2026, 8:00 AM EDT - 12 days ago

HeartSciences Proxy statement: Proxy filing

Jul 23, 2026, 7:00 AM EDT - 12 days ago

HeartSciences Annual report: Q4 2026

Jul 23, 2026, 7:00 AM EDT - 12 days ago

HeartSciences Earnings release: Q4 2026

Jul 22, 2026, 8:00 AM EDT - 13 days ago

HeartSciences Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 25 days ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 24, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

2026-06-23T14:26:04.000Z - 6 weeks ago

HeartSciences, Fortitude announces business combination

Jun 23, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 7:30 AM EDT - 6 weeks ago

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

Jun 23, 2026, 7:00 AM EDT - 6 weeks ago

HeartSciences Slides: Investor presentation

2026-06-11T13:48:30.000Z - 7 weeks ago

HeartSciences granted European patent for heart-monitoring technology

Jun 11, 2026, 8:30 AM EDT - 7 weeks ago

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents

Jun 2, 2026, 8:30 AM EDT - 2 months ago

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

2026-05-19T12:51:09.000Z - 2 months ago

HeartSciences enters commercial agreement with North Shore Health

May 19, 2026, 8:30 AM EDT - 2 months ago

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

2026-05-05T13:47:14.000Z - 3 months ago

HeartSciences signs MyoVista commercial agreement with St. Vincent Health

May 5, 2026, 9:00 AM EDT - 3 months ago

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

Apr 14, 2026, 4:15 PM EDT - 3 months ago

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Mar 25, 2026, 8:30 AM EDT - 4 months ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 24, 2026, 11:18 AM EDT - 4 months ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 19, 2026, 8:00 AM EDT - 4 months ago

HeartSciences Proxy statement: Proxy filing

Mar 17, 2026, 8:00 AM EDT - 5 months ago

HeartSciences Proxy statement: Proxy filing

Mar 16, 2026, 4:15 PM EDT - 5 months ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 8:00 AM EDT - 5 months ago

HeartSciences Quarterly report: Q3 2026

Mar 16, 2026, 8:00 AM EDT - 5 months ago

HeartSciences Earnings release: Q3 2026

Mar 6, 2026, 7:00 AM EST - 5 months ago

HeartSciences Proxy statement: Proxy filing

2026-02-05T13:47:11.000Z - 6 months ago

HeartSciences announces UWE adopted MyoVista Insights, MyoVista wavECG

Feb 5, 2026, 8:30 AM EST - 6 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

2026-01-29T13:41:04.000Z - 6 months ago

HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks

Jan 29, 2026, 8:30 AM EST - 6 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Dec 15, 2025, 4:15 PM EST - 8 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

2025-12-15T13:35:23.000Z - 8 months ago

HeartSciences announces FDA 510(k) submission for MyoVista wavECG

Dec 15, 2025, 8:30 AM EST - 8 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 7:00 AM EST - 8 months ago

HeartSciences Quarterly report: Q2 2026

Dec 15, 2025, 7:00 AM EST - 8 months ago

HeartSciences Earnings release: Q2 2026

2025-12-11T13:46:02.000Z - 8 months ago

HeartSciences announces commercial release of MyoVista Insights version 1.1

Dec 11, 2025, 8:30 AM EST - 8 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Sep 12, 2025, 7:00 AM EDT - 11 months ago

HeartSciences Slides: Investor presentation

Sep 11, 2025, 4:15 PM EDT - 11 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 8:00 AM EDT - 11 months ago

HeartSciences Quarterly report: Q1 2026

Sep 11, 2025, 8:00 AM EDT - 11 months ago

HeartSciences Earnings release: Q1 2026

Aug 15, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Conference Participation and Investor Webinar

Jul 24, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Annual report: Q4 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q4 2025

2025-06-04T13:06:22.000Z - 1 year ago

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

Jun 4, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

2025-06-03T13:05:37.000Z - 1 year ago

HeartSciences announces grant by USPTO for ECG assessment of heart function

Jun 3, 2025, 9:00 AM EDT - 1 year ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

2025-05-29T13:05:18.000Z - 1 year ago

HeartSciences signs first MyoVista Insights platform customer

May 29, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 20, 2025, 9:00 AM EDT - 1 year ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

2025-05-07T13:06:44.000Z - 1 year ago

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

2025-05-01T13:28:48.000Z - 1 year ago

HeartSciences launches MyoVista Insights platform

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Quarterly report: Q3 2025

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q3 2025

2025-03-10T13:10:33.000Z - 1 year ago

HeartSciences engages Integrous Communications to enhance communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Quarterly report: Q2 2025

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Earnings release: Q2 2025

2024-11-13T14:12:03.000Z - 1 year ago

Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 27, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Registration statement: Registration filing

Sep 26, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Proxy statement: Proxy filing

Sep 18, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Proxy statement: Proxy filing

Sep 12, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Quarterly report: Q1 2025

Sep 12, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q1 2025

Jul 29, 2024, 4:05 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Annual report: Q4 2024

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q4 2024

Jul 26, 2024, 9:00 AM EDT - 2 years ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 25, 2024, 8:30 AM EDT - 2 years ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 11, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Quarterly report: Q3 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q3 2024

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 5, 2024, 7:00 AM EST - 2 years ago

HeartSciences Registration statement: Registration filing

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Jan 18, 2024, 7:00 AM EST - 2 years ago

HeartSciences Proxy statement: Proxy filing

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Mikeqb20 Aug. 3 at 11:22 AM

$GIFT $RITR $RCEL $HSCS $CRE MAESTRO LOVES GIFT....

0 · Reply

johnnylawrencecobra Aug. 3 at 9:28 AM

$CRE $GIFT $HSCS $RCEL $RITR $GIFT on HIGH ALERT

0 · Reply

johnnylawrencecobra Aug. 3 at 9:27 AM

$CRE $GIFT $HSCS $RCEL $RITR LOVE $GIFT

0 · Reply

DrTampa Aug. 3 at 8:04 AM

$HSCS volume of 2600 shares at 4:03am is crazy for this stock lol nice spread on level 2

0 · Reply

Zeestallion Aug. 3 at 3:16 AM

0 · Reply

topstockalerts Aug. 3 at 12:23 AM

After Hours Top Gainers PT2 $RITR $GIFT $RCEL $HSCS $CRE

0 · Reply

topstockalerts Aug. 1 at 7:31 PM

After Hours Top Gainers PT2 $RITR $GIFT $RCEL $HSCS $CRE

0 · Reply

Zeestallion Aug. 1 at 5:57 PM

0 · Reply

Mikeqb20 Aug. 1 at 2:53 PM

$RITR $RCEL $HSCS $CRE $GIFT

0 · Reply

topstockalerts Aug. 1 at 1:06 AM

After Hours Top Gainers PT2 $RITR $RCEL $HSCS $CRE $GIFT

0 · Reply

bigxya Aug. 1 at 12:46 AM

$VIVS Folks ⏲️💣🔥💥 The proof is in writting: ✂️ 🔇 ✅️ Liver and GI models show high in ADCs ✅️ Their lab models are better at predicting real human side effects than the old animal tests. That's why big pharma is starting to pay attention. ✅️ Eli Lilly knows this is a game changer for big pharma companies The fuse is lit 🔥 Bottoms in & we going up folks pay attention daddy is home follow the news $UPC $FCUV $HSCS

0 · Reply

topstockalerts Jul. 31 at 10:25 PM

$HSCS this one is sneaking up on people

0 · Reply

Stock_Catcher Jul. 30 at 11:31 AM

$HSCS Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem

0 · Reply

icecoldveins Jul. 30 at 2:14 AM

$HSCS just saw the recent filing on the proposed merger, company is completely lost and officially turning into a scam.

0 · Reply

STACKD0E Jul. 29 at 1:07 PM

$SOUN $SURG $HSCS ✨️

0 · Reply

Flowjob Jul. 28 at 11:41 AM

$HSCS forget about the FDA approval this is some new mining zcash scam company lol

0 · Reply

DrTampa Jul. 23 at 9:03 PM

$HSCS 10-k just dropped. reading it now 🫡

0 · Reply

Moneyybaggs Jul. 12 at 12:25 PM

$HSCS This is dead money for at least 12 months. Oh well, time to move on. Pass the beer nuts!

1 · Reply

focafoca99 Jul. 10 at 9:15 PM

$HSCS outlines a merger with Fortitude Mining and a CFO severance amendment.

0 · Reply

Atlasquantlabs Jul. 2 at 1:25 AM

$KUST overall it’s still a uptrend with strong pull back to the bottom trendline line! We just need one more strong run up and it should get us to the 3 zone! $SKYQ same thing super strong pull backs then it went back up $HSCS same thing, buy the dips and sell the rips.

0 · Reply

Market Cap	2.27M
Revenue (ttm)	20,000.00
Net Income (ttm)	-6.61M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	11,938
Avg Vol	455,542
Day's Range	N/A - N/A
Shares Out	656,000.00
Stochastic %K	24%
Beta	3.16
Analysts	Strong Sell
Price Target	$13.50